A combined assay to screen blood donations for HIV and hepatitis viruses and a test for West Nile virus are now cleared to run on the Procleix Panther system.
A CBS News station in California reports on newborn heel-prick blood spot testing and later use of those samples.
Despite the astronomical costs, it may prove challenging to reverse course and discontinue Zika testing according to a commentary article accompanying a NEJM study.
In a study involving almost 23,000 women, DNA reflex testing detect 95 percent of trisomies while avoiding recalls.
The company credited its molecular diagnostics and international businesses as drivers of new growth.
The assay runs on the Procleix Panther system and detects B. microti, B. duncani, B. divergens, and B. venatorum parasites that can be transmitted by tick bites or blood donation.
Hologic's CEO said in December that the blood screening business was a drag on the company's growth.
The three-year trial used immunoassays and PCR testing, and found 335 Babesia microti positive samples among 89,153 blood donations.
Roche's PCR-based Cobas test is also being deployed at one blood center in the US and is proving to be highly accurate, the agency said.
The Cobas Zika test is a qualitative in vitro nucleic acid screening test for the direct detection of Zika virus in plasma specimens from human blood donors.
With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.
NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.
CNBC reports that there are thousands of genetic tests available for consumers to chose between.
In Nature this week: genomic analysis of ducks, whole-genome doubling among tumor samples, and more.